Skip to main content
Download PDF
- Main
Current Antiretroviral Treatment Among People With Human Immunodeficiency Virus in the United States: Findings from the Centers for AIDS Research Network of Integrated Clinic Systems Cohort
- Ma, Jimmy;
- Nance, Robin M;
- Delaney, Joseph AC;
- Whitney, Bridget M;
- Bamford, Laura;
- Gravett, Ronnie M;
- Moore, Richard D;
- Napravnik, Sonia;
- Mayer, Kenneth H;
- Jacobson, Jeffrey M;
- Christopoulos, Katerina;
- Burkholder, Greer A;
- Keruly, Jeanne;
- Eron, Joseph J;
- Martin, Jeffrey;
- Cachay, Edward R;
- Saag, Michael S;
- Crane, Heidi M;
- Kitahata, Mari M
- et al.
Published Web Location
https://doi.org/10.1093/cid/ciac086Abstract
Among 14 049 people with human immunodeficiency virus in care in 2019-2020, 96% were treated with antiretroviral therapy (ART). Current antiretroviral treatment patterns highlight high uptake of guideline-recommended ART regimens including second-generation integrase strand transfer inhibitors (dolutegravir and bictegravir) and tenofovir alafenamide, especially in antiretroviral-naive individuals initiating ART.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
For improved accessibility of PDF content, download the file to your device.
Enter the password to open this PDF file:
File name:
-
File size:
-
Title:
-
Author:
-
Subject:
-
Keywords:
-
Creation Date:
-
Modification Date:
-
Creator:
-
PDF Producer:
-
PDF Version:
-
Page Count:
-
Page Size:
-
Fast Web View:
-
Preparing document for printing…
0%